Insights

Tech Stack Ziopharm Oncology utilizes modern tech stack including Akamai, WordPress, React, and more, indicating a potential need for technology solutions or integrations.

Strategic Reprioritization The recent strategic reprioritization by Alaunos Therapeutics to focus on hunTR TCR discovery platform presents a sales opportunity for companies offering complementary services or technologies in this field.

Collaborative Partnerships Partnerships like the one with Precigen for CAR-T development showcase a willingness to collaborate, creating openings for partnerships or joint ventures with Ziopharm Oncology.

Key Personnel Appointment The hiring of Robert J. Hofmeister as CSO highlights a focus on scientific leadership, suggesting opportunities for scientific advisory services or collaborations.

Public Offering The recent public offering by Ziopharm Oncology indicates potential investment opportunities or partnerships for financial services firms looking to engage with the biotechnology sector.

Ziopharm Oncology Tech Stack

Ziopharm Oncology uses 8 technology products and services including Akamai, WordPress, React, and more. Explore Ziopharm Oncology's tech stack below.

  • Akamai
    Content Delivery Network
  • WordPress
    Content Management System
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Lua
    Programming Languages
  • X-XSS-Protection
    Security
  • Drupal Multisite
    Web Hosting

Media & News

Ziopharm Oncology's Email Address Formats

Ziopharm Oncology uses at least 2 format(s):
Ziopharm Oncology Email FormatsExamplePercentage
last@ziopharm.comDoe@ziopharm.com
45%
first.last@ziopharm.comJohn.Doe@ziopharm.com
19%
f.last@ziopharm.comJ.Doe@ziopharm.com
9%
flast@ziopharm.comJDoe@ziopharm.com
9%
fmiddlelast@ziopharm.comJMichaelDoe@ziopharm.com
9%
lfirst@ziopharm.comDJohn@ziopharm.com
9%
first@alaunos.comJohn@alaunos.com
33%
first.last@alaunos.comJohn.Doe@alaunos.com
34%
flast@alaunos.comJDoe@alaunos.com
33%

Frequently Asked Questions

Where is Ziopharm Oncology's headquarters located?

Minus sign iconPlus sign icon
Ziopharm Oncology's main headquarters is located at 8030 El Rio St Houston, Texas 77054 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Ziopharm Oncology's phone number?

Minus sign iconPlus sign icon
You can contact Ziopharm Oncology's main corporate office by phone at +1-617-259-1970. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ziopharm Oncology's stock symbol?

Minus sign iconPlus sign icon
Ziopharm Oncology is a publicly traded company; the company's stock symbol is TCRT.

What is Ziopharm Oncology's official website and social media links?

Minus sign iconPlus sign icon
Ziopharm Oncology's official website is alaunos.com and has social profiles on LinkedIn.

What is Ziopharm Oncology's SIC code NAICS code?

Minus sign iconPlus sign icon
Ziopharm Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ziopharm Oncology have currently?

Minus sign iconPlus sign icon
As of February 2022, Ziopharm Oncology has approximately 52 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Vice President Project And Portfolio Management: C. V.Vice President Raqa: K. P.Vice President Raqa: K. P.. Explore Ziopharm Oncology's employee directory with LeadIQ.

What industry does Ziopharm Oncology belong to?

Minus sign iconPlus sign icon
Ziopharm Oncology operates in the Biotechnology Research industry.

What technology does Ziopharm Oncology use?

Minus sign iconPlus sign icon
Ziopharm Oncology's tech stack includes AkamaiWordPressReactjQueryModernizrLuaX-XSS-ProtectionDrupal Multisite.

What is Ziopharm Oncology's email format?

Minus sign iconPlus sign icon
Ziopharm Oncology's email format typically follows the pattern of . Find more Ziopharm Oncology email formats with LeadIQ.

How much funding has Ziopharm Oncology raised to date?

Minus sign iconPlus sign icon
As of February 2022, Ziopharm Oncology has raised $8.4M in funding. The last funding round occurred on Sep 13, 2019.
Ziopharm Oncology

Ziopharm Oncology

Biotechnology ResearchTexas, United States51-200 Employees

Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.

Section iconCompany Overview

Headquarters
8030 El Rio St Houston, Texas 77054 US
Phone number
+1-617-259-1970
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TCRT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $8.4M

    Ziopharm Oncology has raised a total of $8.4M of funding over 8 rounds. Their latest funding round was raised on Sep 13, 2019.

Section iconFunding & Financials

  • $8.4M

    Ziopharm Oncology has raised a total of $8.4M of funding over 8 rounds. Their latest funding round was raised on Sep 13, 2019.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.